Bearish signal on daily chart
In the last 7 years, only 1.61 % trading sessions saw intraday declines higher than 5 % .
Potential
Upside
1 Year
Target
BUY
Mean Recos by
8 Analysts
/10
Stock Score
Earnings | |
Fundamentals | |
Relative Valuation | |
Risk | |
Price Momentum |
In the last 7 years, only 1.61 % trading sessions saw intraday declines higher than 5 % .
Company delivered ROE of 156.87% in year ending Mar 31, 2025 outperforming its 5 year avg. of 34.07%. (Source: Consolidated Financials)
Company's annual revenue growth of 15.12% outperformed its 3 year CAGR of -25.13%. (Source: Consolidated Financials)
5 day moving crossover appeared today. Average price decline of -2.33% within 7 days of this signal in last 5 years.
Aster DM Healthcare Ltd. share price moved down by -1.54% from its previous close of Rs 578.25. Aster DM Healthcare Ltd. stock last traded price is 569.40
Share Price | Value |
---|---|
Today/Current/Last | 569.40 |
Previous Day | 578.25 |
PE Ratio (x) | 5.45 | ||||||||||
EPS - TTM (₹) | 107.66 | ||||||||||
MCap (₹ Cr.) | 30,403.34 | ||||||||||
Sectoral MCap Rank | 6 | ||||||||||
PB Ratio (x) | 8.03 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 1.70 | ||||||||||
VWAP (₹) | 570.94 | ||||||||||
52W H/L (₹) |
1 Day | -1.54% |
1 Week | 2.95% |
1 Month | 7.54% |
3 Months | 36.4% |
1 Year | 58.08% |
3 Years | 191.78% |
5 Years | 463.48% |
Current
Mean Recos by 8 Analysts
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 4 | 4 | 5 | 5 |
Buy | 3 | 3 | 3 | 3 |
Hold | 1 | 1 | - | - |
Sell | - | - | - | - |
Strong Sell | - | - | - | - |
# Analysts | 8 | 8 | 8 | 8 |
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 15.12% outperformed its 3 year CAGR of -25.13%. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent 2.99% of its operating revenues towards interest expenses and 18.37% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)Quarterly | Annual | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|---|
Total Income | 1,031.62 | 1,082.80 | 1,121.68 | 1,050.59 | 977.67 |
Total Income Growth (%) | -4.73 | -3.47 | 6.77 | 7.46 | -73.71 |
Total Expenses | 898.64 | 946.56 | 928.97 | 898.74 | 872.61 |
Total Expenses Growth (%) | -5.06 | 1.89 | 3.36 | 2.99 | -74.17 |
EBIT | 132.98 | 136.24 | 192.71 | 151.85 | 105.06 |
EBIT Growth (%) | -2.39 | -29.30 | 26.91 | 44.54 | -69.15 |
Profit after Tax (PAT) | 79.02 | 56.79 | 96.84 | 5,145.18 | -24.03 |
PAT Growth (%) | 39.14 | -41.36 | -98.12 | - | -113.41 |
EBIT Margin (%) | 12.89 | 12.58 | 17.18 | 14.45 | 10.75 |
Net Profit Margin (%) | 7.66 | 5.24 | 8.63 | 489.74 | -2.46 |
Basic EPS (₹) | 1.59 | 1.14 | 1.94 | 103.34 | -0.48 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Total Assets | 6,606.38 | 17,991.31 | 14,881.20 | 12,546.24 | 11,643.46 |
Total Assets Growth (%) | -63.28 | 20.90 | 18.61 | 7.75 | -6.39 |
Total Liabilities | 2,954.93 | 12,961.20 | 10,020.74 | 8,063.62 | 7,809.34 |
Total Liabilities Growth (%) | -77.20 | 29.34 | 24.27 | 3.26 | -10.44 |
Total Equity | 3,651.45 | 5,030.11 | 4,486.08 | 4,482.62 | 3,834.12 |
Total Equity Growth (%) | -27.41 | 12.13 | 0.08 | 16.91 | 14.65 |
Current Ratio (x) | 2.16 | 1.25 | 1.06 | 1.15 | 1.14 |
Total Debt to Equity (x) | 0.19 | 0.15 | 0.56 | 0.55 | 0.57 |
Contingent Liabilities | 0.00 | 480.16 | 365.46 | 381.30 | 299.39 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Net Cash flow from Operating Activities | 425.05 | 157.81 | 1,833.98 | 1,313.46 | 1,569.12 |
Net Cash used in Investing Activities | 6,014.87 | -884.65 | -971.88 | -570.48 | -330.30 |
Net Cash flow from Financing Activities | -6,357.81 | 1,052.83 | -817.39 | -685.42 | -1,116.13 |
Net Cash Flow | 82.36 | 332.39 | 65.74 | 64.78 | 119.90 |
Closing Cash & Cash Equivalent | 164.59 | 697.46 | 365.07 | 299.33 | 234.55 |
Closing Cash & Cash Equivalent Growth (%) | -76.40 | 91.05 | 21.96 | 27.62 | 104.58 |
Total Debt/ CFO (x) | 1.51 | 4.24 | 1.25 | 1.67 | 1.22 |
All figures in Rs Cr, unless mentioned otherwise
ROE Outperforming 5 Year Average
Company delivered ROE of 156.87% in year ending Mar 31, 2025 outperforming its 5 year avg. of 34.07%. (Source: Consolidated Financials)Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Return on Equity (%) | 156.87 | 2.83 | 10.43 | 13.30 | 4.38 |
Return on Capital Employed (%) | 11.59 | 5.71 | 8.44 | 9.93 | 5.86 |
Return on Assets (%) | 81.40 | 0.71 | 2.85 | 4.19 | 1.26 |
Interest Coverage Ratio (x) | 7.37 | 5.47 | 4.99 | 5.97 | 1.69 |
Asset Turnover Ratio (x) | 0.34 | 0.23 | 0.18 | 0.14 | 73.93 |
Price to Earnings (x) | 4.50 | 158.73 | 28.41 | 18.62 | 46.30 |
Price to Book (x) | 7.06 | 4.48 | 2.96 | 2.48 | 2.02 |
EV/EBITDA (x) | 25.97 | 35.61 | 8.72 | 7.91 | 8.02 |
EBITDA Margin (%) | 22.05 | 16.29 | 13.77 | 14.96 | 12.92 |
Bullish / Bearish signals for Aster DM Health basis selected technical indicators and moving average crossovers.
5 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 9 Jun 2025
5D EMA: 571.86
Date | 7 days Gain/Loss % |
---|---|
23 May 2025 | -3.11% |
21 May 2025 | -0.35% |
30 Apr 2025 | -1.58% |
25 Apr 2025 | -0.93% |
Average price decline of -2.33% within 7 days of Bearish signal in last 5 years
10 Day EMA Crossover
Bullish signal on daily chart
Appeared on: 30 May 2025
10D EMA: 553.07
Date | 7 days Gain/Loss % |
---|---|
22 May 2025 | 0.43% |
5 Mar 2025 | 6.53% |
31 Jan 2025 | -2.71% |
23 Dec 2024 | 3.60% |
Average price gain of 4.03% within 7 days of Bullish signal in last 5 years
R1 | R2 | R3 | PIVOT | S1 | S2 | S3 | |
---|---|---|---|---|---|---|---|
Classic | - | - | - | - | - | - | - |
5 DAYS | 14 DAYS | 28 DAYS | |
---|---|---|---|
ATR | 22.55 | 21.42 | 19.92 |
Choose from Peers
Choose from Stocks
MF Ownership details are not available.
Meeting Date | Announced on | Purpose | Details |
---|---|---|---|
May 20, 2025 | May 14, 2025 | Board Meeting | Audited Results & Final Dividend |
Jan 31, 2025 | Jan 27, 2025 | Board Meeting | Quarterly Results & Interim Dividend |
Dec 31, 2024 | Dec 02, 2024 | POM | - |
Oct 23, 2024 | Oct 17, 2024 | Board Meeting | Quarterly Results |
Jul 31, 2024 | Jul 25, 2024 | Board Meeting | Quarterly Results |
Type | Dividend | Dividend per Share | Ex-Dividend Date | Announced on |
---|---|---|---|---|
Interim | 40% | 4.0 | Feb 10, 2025 | Jan 27, 2025 |
Final | 20% | 2.0 | Aug 22, 2024 | May 28, 2024 |
Interim | 0% | 0.0 | Apr 23, 2024 | Apr 05, 2024 |
Special | 1180% | 118.0 | Apr 23, 2024 | Apr 05, 2024 |
Final | 10% | 1.0 | - | May 20, 2025 |
No other corporate actions details are available.
Aster DM Healthcare Ltd., incorporated in the year 2008, is a Mid Cap company (having a market cap of Rs 30,403.34 Crore) operating in Hospitals & Allied Services sector. Aster DM Healthcare Ltd. key Products/Revenue Segments include Hospital Services, Pharmaceuticals, Other Operating Revenue, Other Services and Consultancy Income for the year ending 31-Mar-2024. Show More
Azad Moopen
Founder Chairman & Mng. DirectorAlisha Moopen
Deputy Managing DirectorNitish Shetty
Chief Executive OfficerDaniel Robert Mintz
Non Executive DirectorIndustry
Key Indices Listed on
Nifty Smallcap 100, Nifty 500, BSE 500, + 13 more
Address
Awfis, 2nd Floor, Renaissance Centra,27 & 27/1, Mission Road,Sampangi Rama Nagar,Bengaluru, Kerala - 560027
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.